These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 9324471)
1. [Pharmacologic suppression of the ovarian function and its clinical usefulness]. Kershenovich Sefchovich R; Kably Ambe A; García Morales MA; Peryra Quiñones R; Barrón Vallejo J Ginecol Obstet Mex; 1997 Aug; 65():344-8. PubMed ID: 9324471 [TBL] [Abstract][Full Text] [Related]
2. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats]. Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495 [TBL] [Abstract][Full Text] [Related]
3. Role, mechanism of action and application of gonadoliberins in reproductive processes. Teplán I Acta Biol Hung; 1989; 40(1-2):3-36. PubMed ID: 2561244 [TBL] [Abstract][Full Text] [Related]
4. G protein-coupled receptors of the hypothalamic-pituitary-gonadal axis: a case for Gnrh, LH, FSH, and GPR54 receptor ligands. Heitman LH; Ijzerman AP Med Res Rev; 2008 Nov; 28(6):975-1011. PubMed ID: 18561294 [TBL] [Abstract][Full Text] [Related]
5. Ovarian stimulation with FSH in the rat reduces proestrous GnRH-dependent LH secretion through a dual mechanism: inhibition of LH synthesis and release. Gordon A; Garrido-Gracia JC; Aguilar R; Sánchez-Criado JE Neurosci Lett; 2009 Sep; 460(3):219-22. PubMed ID: 19477224 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells. Choi JH; Choi KC; Auersperg N; Leung PC Endocr Relat Cancer; 2006 Jun; 13(2):641-51. PubMed ID: 16728589 [TBL] [Abstract][Full Text] [Related]
8. Evidence that gonadotropin-releasing hormone (GnRH) II stimulates luteinizing hormone and follicle-stimulating hormone secretion from monkey pituitary cultures by activating the GnRH I receptor. Okada Y; Murota-Kawano A; Kakar SS; Winters SJ Biol Reprod; 2003 Oct; 69(4):1356-61. PubMed ID: 12801988 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study. Graña-Barcia M; Liz-Lestón J; Lado-Abeal J Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586 [TBL] [Abstract][Full Text] [Related]
10. Gonadotropin-releasing hormone and its receptor in normal and malignant cells. Harrison GS; Wierman ME; Nett TM; Glode LM Endocr Relat Cancer; 2004 Dec; 11(4):725-48. PubMed ID: 15613448 [TBL] [Abstract][Full Text] [Related]
11. Gonadotropin-releasing hormone (GnRH) analogues and the ovary: do GnRH antagonists destroy primordial follicles? Gupta RK; Flaws JA Fertil Steril; 2005 May; 83(5):1339-42. PubMed ID: 15866566 [TBL] [Abstract][Full Text] [Related]
12. Pituitary and extrapituitary actions of gonadotrophin-releasing hormone and its analogues. Ortmann O; Diedrich K Hum Reprod; 1999 Sep; 14 Suppl 1():194-206. PubMed ID: 10573034 [TBL] [Abstract][Full Text] [Related]
13. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction. Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360 [TBL] [Abstract][Full Text] [Related]
14. Testosterone effects on luteinizing hormone and follicle-stimulating hormone responses to gonadotropin-releasing hormone in the mouse. Huang BM; Leu SF; Yang HY; Norman RL J Androl; 2001; 22(3):507-13. PubMed ID: 11330652 [TBL] [Abstract][Full Text] [Related]
15. Biological characterization of a novel, orally active small molecule gonadotropin-releasing hormone (GnRH) antagonist using castrated and intact rats. Anderes KL; Luthin DR; Castillo R; Kraynov EA; Castro M; Nared-Hood K; Gregory ML; Pathak VP; Christie LC; Paderes G; Vazir H; Ye Q; Anderson MB; May JM J Pharmacol Exp Ther; 2003 May; 305(2):688-95. PubMed ID: 12606616 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of growth and proliferation of EcRG293 cell line expressing high-affinity gonadotropin-releasing hormone (GnRH) receptor under the control of an inducible promoter by GnRH agonist (D-Lys6)GnRH and antagonist (Antide). Kakar SS Cancer Res; 1998 Oct; 58(20):4558-60. PubMed ID: 9788600 [TBL] [Abstract][Full Text] [Related]
18. [GnRH agonists. New possibility for treatment of hormone-dependent gynecologic diseases]. Bergqvist A; Bergquist C Lakartidningen; 1993 Mar; 90(12):1155-8, 1163. PubMed ID: 8385729 [No Abstract] [Full Text] [Related]
19. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone. Engel JB; Schally AV Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):157-67. PubMed ID: 17237842 [TBL] [Abstract][Full Text] [Related]
20. GnRH receptor and GPR54 inactivation in isolated gonadotropic deficiency. de Roux N Best Pract Res Clin Endocrinol Metab; 2006 Dec; 20(4):515-28. PubMed ID: 17161329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]